MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$288,284K
Interest income
$37,364K
Loss from operations
-$300,097K
Product revenue, net
$958,403K
Interest expense
$22,309K
Loss on
extinguishment of debt
-$2,779K
Other expense, net
-$463K
Total operating
expenses
$1,258,500K
Selling, general and
administrative
$813,827K
Research and development
$388,525K
Cost of sales
$56,148K
Back
Back
Income Statement
source: myfinsight.com
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)